Among other lines of evidence, the connection between obesity, hyperinsulinemia and enhanced cancer risk provides a biologically plausible rationale for a key role of insulin and the INSR in breast cancer initiation and/or progression. Here, INSR is linked to obesity due to melanocortin 4 receptor deficiency.